Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
about
The genome of canarypox virusHuman cytomegalovirus: detection of congenital and perinatal infection in ArgentinaVaccines: the Fourth CenturySystemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeA spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.New and emerging vaccination strategies for prevention and treatment of dermatological diseases.Vaccine strategies against human cytomegalovirus infection.Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.A CMV vaccine: TREATing despite the TRICKs.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.Immune-based therapies for cytomegalovirus infection.Innate immune recognition of poxviral vaccine vectors.Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV.Glycoprotein B genotyping in congenital/perinatal Cytomegalovirus infection in symptomatic infants.Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
P2860
Q24630284-0A62BCF2-B21B-4465-A862-DB5F1B9AA9A1Q24801969-8204247A-19A0-43DE-87DC-A3C3A64FBA46Q27490454-8E1E5E74-E36F-45F6-B39A-E5E6FEE77078Q33551402-892AE0F3-6BDF-4AB2-ADD9-BE5C8A13EF6CQ33964131-49AD7AA1-4BF4-4753-BA32-D17AB1CF8402Q34120904-FF910358-F575-4EAD-970A-41CCEB5ABD96Q34349745-BA432948-7D93-4641-B2EC-720A07CB75CCQ34360228-7E26F800-76A2-4AE3-96DF-EF48CFE3239DQ34975513-E373DCF1-108B-4F63-AEA9-95562FB89067Q35843635-69C4A5D4-88E9-43BC-ACF5-BF09C5887FA6Q36839736-A3C2F7FD-1AD0-4AAF-ABAC-2242EC1B55D2Q37243886-EA985556-2BAE-44A1-A392-387A82C555D5Q37409233-05D605C0-F3BC-4159-A627-3D0D825E162AQ37523988-344EDA4B-D33C-4D9B-92B3-09CBD102E9B5Q37559627-A8EECB05-A270-4306-8D26-A6DD0F65158CQ37680941-566EC85D-23AF-49A2-A99F-38CF6A2636C4Q37773240-D50AC11E-AC69-439A-9261-F82FA5771676Q37944321-5F177B16-9F2C-4DC0-9C23-B570E22C9BD6Q39629189-6C87F78D-BC0D-4BA1-8B65-9ADC841842B5Q46121992-2F73D38E-9297-419A-B07A-C6F9AF81F7BDQ48331811-E575D497-95F6-4D67-B326-1522CE0CDEBF
P2860
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@ast
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@en
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@nl
type
label
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@ast
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@en
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@nl
prefLabel
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@ast
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@en
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@nl
P2860
P356
P1476
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
@en
P2093
P2860
P304
P356
10.1517/14712598.1.3.401
P407
P50
P577
2001-05-01T00:00:00Z